$0.5243
0.1644.83%
At close: Aug 5, 5:00 PM EST
$0.4693
0.1129.64%
Pre-Market: 5:51 AM EST
Ensysce Biosciences Inc
ENSCNASDAQ
PRO
M&A: Cy Biopharma, Inc was acquired by Ensysce Biosciences (ENSC) on Thursday, August 6, 2026
Ensysce Biosciences Market Sentiment
Market sentiment signals for Ensysce Biosciences (ENSC): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 2.6% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Buy
1 analysts
Options Flow (P/C)
—
Avg Consensus PT
$7
+1391.6%
Highest Price Target
$7
+1391.6%
HC Wainwright & Co.
Lowest Price Target
$7
+1391.6%
HC Wainwright & Co.
Short Interest
2.6%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 25, 2023 | HC Wainwright & Co. | Raghuram Selvaraju— | +1391.6% | $9 → $7 | Maintained | Buy |
